Events Archives | Page 5 of 9 | Vein Therapy News

CAN SOMEONE TELL ME WHAT A PBM REALLY DOES?

By Rachel Bluth It was back-to-school day at the Senate Finance Committee hearing April 9. In the third of a series of hearings on rising drug prices, the senators seemed focused on getting an answer to one central question: What…

Teleflex gets premarket OK for biomechanical MANTA Closure

Teleflex Inc., a global provider of medical technologies for critical care and surgery, has announced that it received premarket approval from the U.S. Food and Drug Administration for the MANTA Vascular Closure Device – the first commercially available biomechanical…

March282019November292024

A NEW RF SYSTEM: VENCLOSE 2ND GENERATION RADIOFREQUENCY TECHNOLOGY OUTPERFORMS LEGACY SYSTEM

By Larry Storer The great medical technology companies of our time start and develop in a variety of ways. Some start with a product or idea and built a market around it. Some start as spinoffs from existing…

FDA evaluating stents, balloons with paclitaxel coating following JAHA evaluation

A December study in The Journal of the American Heart Association by Konstantinos Katsanos, MD, of Rion, Greece, et al, reported a higher risk of death after balloons and stents used to open vessels in the legs were coated with…

INTERVENTIONAL RADIOLOGY SOCIETIES CALL FOR EXPANDED STROKE TRAINING

The Society of Interventional Radiology (SIR), the Cardiovascular and Interventional Radiology Society of Europe and the Interventional Radiology Society of Australasia have formed a Joint Commission committed to providing necessary stroke training to interventional radiologists in order to alleviate the shortage of…

MDLINX SURVEY: MAJORITY HAVE LOST FAITH IN VALUE OF THE MOC

A survey of 515 U.S. physicians by MDLinx revealed that 65 percent want to see the 10-year maintenance of certification (MOC) process ended because it adds no clinical value to the practice of medicine. The recent survey, reported in FierceHealthcare, found that…

MEDTRONIC GETS OK TO STUDY PATIENTS WITH BICUSPID AORTIC VALUES USING COREVALVE EVOLUT TAVR SYSTEM

The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for Medtronic to initiate a single-arm study to evaluate the CoreValve Evolut TAVR system in patients with bicuspid aortic valves who are at low risk of…

IT’S A LITTLE-KNOWN SECRET THAT PATIENTS CAN GET THOUSANDS OF DOLLARS DIRECTLY FROM A DRUGMAKER

By Sarah Jane Tribble Kip Burgess was relieved last year when pharmaceutical giant Amgen overnighted him a $2,976 check to help pay for his go-to arthritis drug, Enbrel. The 36-year-old psychologist had run into an increasingly common…

January32019November292024

IN.PACT ADMIRAL: MEDTRONIC SHARES FIVE-YEAR DRUG-COATED BALLOON DATA

Medtronic plc data presented Nov. 12 reinforce the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral artery disease in the superficial femoral and popliteal arteries. The five-year and final results from the…

KENNETH OSORIO, MD: A successful vein specialist leads missions of mercy to Caraz, Peru

By John A. Chuback, MD, FACS, RPVI, RVT, RPhS Kenneth Osorio, MD, is a successful phlebologist and the medical director of Advanced Vein Center, a very active clinical practice in Mesa, Arizona. Despite his many professional accomplishments, he…